Stay updated with breaking news from Philippe Legenne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Molecular Partners AG ((SIX: MOLN, NASDAQ:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs
H1 2023 BUSINESS UPDATE AND FINANCIAL STATEMENTS Contents ...
RDT platform offers unique approach for tailored delivery of radioactive payloads to solid tumors RDT platform is focused on improving both...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.